Zacks
Why Is Avanos Medical (AVNS) Down 0.5% Since Last Earnings Report?
➖
AI Sentiment
Neutral
5/10
- Home
- AVNS
AVNS
Avanos Medical Inc.
as of 12-10-2025 2:12pm EST
$11.65
+$0.27
+2.37%
Avanos Medical Inc is a United States-based company that develops and sells medical devices and related services globally. Its operating and reportable segment provides medical device products to healthcare providers and patients. The company has now changed two franchises: has combined Chronic Care and Pain Management franchises into a single commercial organization focused on the Digestive Health and Pain Management and Recovery product categories that generate its revenue from its Chronic Care franchise and in North America.
Chart Type:
Time Range:
| Founded: | 2014 | Country: | United States |
| Employees: | N/A | City: | ALPHARETTA |
| Market Cap: | 521.7M | IPO Year: | N/A |
| Target Price: | N/A | AVG Volume (30 days): | 512.3K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -10.15 | EPS Growth: | N/A |
| 52 Week Low/High: | $9.30 - $19.00 | Next Earning Date: | 11-05-2025 |
| Revenue: | $699,900,000 | Revenue Growth: | 2.70% |
| Revenue Growth (this year): | 3.07% | Revenue Growth (next year): | 2.16% |
AI-Powered AVNS Daily Prediction
Machine learning model trained on 25+ technical indicators
Updated 20 hours ago
AI Recommendation
hold
Model Accuracy: 77.55%
77.55%
Confidence
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Stock Insider Trading Activity of Avanos Medical Inc. (AVNS)
Holbrook Kerr
Sell
SVP, Chief Commercial Officer
AVNS Nov 18, 2025
Avg Cost/Share
$11.01
Shares
15,000
Total Value
$165,014.21
Owned After
85,026
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| Holbrook Kerr | AVNS | SVP, Chief Commercial Officer | Nov 18, 2025 | Sell | $11.01 | 15,000 | $165,014.21 | 85,026 |
Latest Avanos Medical Inc. News
AVNS Breaking Stock News: Dive into AVNS Ticker-Specific Updates for Smart Investing
Compare AVNS vs Leading Stocks
See how AVNS stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "AVNS Avanos Medical Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.